| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 09/20/2011 | CA2354475C Blends of isoflavones and flavones |
| 09/20/2011 | CA2337100C Polypeptides of lymphodendritic cell adhesion molecules (ldcams) and polynucleotides encoding the same |
| 09/15/2011 | WO2011113065A2 Pegylated polyplexes for polynucleotide delivery |
| 09/15/2011 | WO2011113048A2 Modulation of cytokine signaling |
| 09/15/2011 | WO2011113015A2 Antisense modulation of nuclear hormone receptors |
| 09/15/2011 | WO2011113013A2 Methods and compositions for treating viral or virally-induced conditions |
| 09/15/2011 | WO2011112995A1 Imidazopyridines syk inhibitors |
| 09/15/2011 | WO2011112893A2 Compositions for ameliorating cell proliferative disorders and methods of making and using them |
| 09/15/2011 | WO2011112873A2 Extracorporeal immunoadsorption treatment |
| 09/15/2011 | WO2011112850A2 Humanized and chimeric anti-properdin antibodies |
| 09/15/2011 | WO2011112766A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/15/2011 | WO2011112732A2 Methods of treating vascular inflammatory disorders |
| 09/15/2011 | WO2011112731A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/15/2011 | WO2011112687A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/15/2011 | WO2011112662A1 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| 09/15/2011 | WO2011112588A2 Compositions and methods for treating inflammatory disorders |
| 09/15/2011 | WO2011111809A1 Ketoprofen-containing aqueous adhesive skin patch |
| 09/15/2011 | WO2011111714A1 Novel ep4 agonist |
| 09/15/2011 | WO2011111143A1 Medicament for rheumatoid arthritis |
| 09/15/2011 | WO2011110852A1 Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide |
| 09/15/2011 | WO2011110824A1 Bis aromatic compounds for use as ltc4 synthase inhibitors |
| 09/15/2011 | WO2011110613A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 09/15/2011 | WO2011110612A1 Inhibitors of protein kinases |
| 09/15/2011 | WO2011065657A3 Compound comprising extracts or fractions of chrysanthemum boreale makino having anti-inflammation activity |
| 09/15/2011 | WO2011060427A9 Composition and methods for affecting cytokines and nf-kb |
| 09/15/2011 | US20110224723 Cyanoacrylate tissue adhesives |
| 09/15/2011 | US20110224675 Minimally invasive treatment of vertebra (mitv) using a calcium phosphate combination bone cement |
| 09/15/2011 | US20110224302 Difluorophenyldiacylhydrazide derivatives |
| 09/15/2011 | US20110224301 Hmgb1 expression and protective role of semapimod in nec |
| 09/15/2011 | US20110224295 Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
| 09/15/2011 | US20110224285 Oligomeric compounds for the modulation of hif-1a expression |
| 09/15/2011 | US20110224283 Antisense modulation of nuclear hormone receptors |
| 09/15/2011 | US20110224276 optical isomer of phenylpropionic acid and its medicinal use |
| 09/15/2011 | US20110224275 Inhibitors of matrix metalloproteinases |
| 09/15/2011 | US20110224268 Compositions and methods of using R(+) pramipexole |
| 09/15/2011 | US20110224267 Selective androgen receptor modulators |
| 09/15/2011 | US20110224262 Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 09/15/2011 | US20110224259 Novel inhibitors |
| 09/15/2011 | US20110224250 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient |
| 09/15/2011 | US20110224248 Azaquinolones that inhibit prolyl hydroxylase |
| 09/15/2011 | US20110224246 Pharmaceutical compositions comprising ascomycin |
| 09/15/2011 | US20110224238 6, 9-Disubstituted Purine Derivatives and Their Use for Treating Skin |
| 09/15/2011 | US20110224229 Novel Crystalline Form |
| 09/15/2011 | US20110224225 Inhibitors of protein kinases |
| 09/15/2011 | US20110224217 Methods of treatment using heteroaryl compounds and compositions thereof |
| 09/15/2011 | US20110224216 Methods of Treating or Preventing Acute Erythema |
| 09/15/2011 | US20110224209 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1) |
| 09/15/2011 | US20110224206 Triazole compounds that modulate hsp90 activity |
| 09/15/2011 | US20110224192 3-Arylamino Pyridine Derivatives |
| 09/15/2011 | US20110224190 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| 09/15/2011 | US20110224188 DERIVATIVES OF 6,7-DIHYDRO-5H-IMIDAZO[1,2-alpha]IMIDAZOLE-3-CARBOXYLIC ACID AMIDES |
| 09/15/2011 | US20110224187 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof |
| 09/15/2011 | US20110224174 Creatine ester anti-inflammatory compounds and formulations |
| 09/15/2011 | US20110224172 Substituted 1-Oxa-2,8-Diaza-Spiro [4,5] Dec-2-Ene Derivatives and Related Treatment Methods |
| 09/15/2011 | US20110224171 Inhibitors of fatty acid amide hydrolase |
| 09/15/2011 | US20110224166 COMPOSITION FOR ACTIVATING MITOCHONDRIA (As Amended) |
| 09/15/2011 | US20110224162 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity of the inflammatory response |
| 09/15/2011 | US20110224138 Methods for treating pain induced by injuries and diseases of an articular joint |
| 09/15/2011 | US20110224132 Use of the long pentraxin ptx3 for the prevention or treatment of viral diseases |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223271 Phytocomplex from bergamot fruit, process of manufacture and use as dietary supplement and in the pharmaceutical field |
| 09/15/2011 | US20110223249 Extended release compositions comprising mycophenolate sodium and processes thereof |
| 09/15/2011 | US20110223238 Bisbenzamidines for the Treatment of Pneumonia |
| 09/15/2011 | US20110223233 Microfabricated nanopore device for sustained release of therapeutic agent |
| 09/15/2011 | US20110223232 drug-release composition having a therapeutic carrier |
| 09/15/2011 | US20110223214 Use of carboxymethylcellulose to control ejectability and solidification time of compositions comprising one or more bioresorbable ceramics |
| 09/15/2011 | US20110223212 Drug eluting superhydrophobic coatings |
| 09/15/2011 | US20110223208 Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations |
| 09/15/2011 | US20110223204 Treatment of pain with gap junction modulation compounds |
| 09/15/2011 | US20110223193 Method for the preparation of medical devices and devices obtained therefrom |
| 09/15/2011 | US20110223165 Humanized C-Kit Antibody |
| 09/15/2011 | US20110223141 Treatment of brain or spinal cord injury using placental stem cells |
| 09/15/2011 | US20110223138 Mesenchymal stem cells that express increased amounts of anti-apoptotic proteins |
| 09/15/2011 | US20110223130 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE |
| 09/15/2011 | US20110223127 SDF-1 Binding Nucleic Acids And The Use Thereof |
| 09/15/2011 | US20110220265 Preparation for External Use |
| 09/15/2011 | CA2811221A1 Humanized and chimeric anti-properdin antibodies |
| 09/15/2011 | CA2795977A1 Method of treatment |
| 09/15/2011 | CA2792769A1 Imidazopyridines syk inhibitors |
| 09/15/2011 | CA2792508A1 Piperidin-4-yl azetidine derivatives as jak1 inhibitors |
| 09/15/2011 | CA2792503A1 Analgesic compounds, compositions, and uses thereof |
| 09/15/2011 | CA2792403A1 Novel ep4 agonist |
| 09/15/2011 | CA2791498A1 Ketoprofen-containing water-based patch |
| 09/15/2011 | CA2791417A1 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 09/15/2011 | CA2789440A1 Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5) |
| 09/15/2011 | CA2789189A1 Inhibitors of protein kinases |
| 09/14/2011 | EP2365000A2 Improved nanobodiesTM against tumor necrosis factor-alpha |
| 09/14/2011 | EP2364994A1 Purfied primate CTLA-8 antigens and related reagents |
| 09/14/2011 | EP2364982A1 Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof |
| 09/14/2011 | EP2364975A1 Novel amide derivative and use thereof as medicine |
| 09/14/2011 | EP2364731A2 Methods of administering anti-TNFalpha antibodies |
| 09/14/2011 | EP2364729A2 IL-17 antagonistic antibodies |
| 09/14/2011 | EP2364727A2 Molecular antigen array |
| 09/14/2011 | EP2364719A1 Prevention and treatment of amyloidogenic diseases |
| 09/14/2011 | EP2364089A1 Heterobicyclic sphingosine 1-phosphate analogs |
| 09/14/2011 | EP2364088A1 Bicyclic aryl sphingosine 1-phosphate analogs |
| 09/14/2011 | EP2225241B1 Derivatives of N-phenyl-imidazo-(1,2-A)-pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 09/14/2011 | EP2185530B1 5-phenyl-isoxazole-3-carboxamide derivatives as trpv1 modulators |
| 09/14/2011 | EP2079731B1 Novel substituted piperidyl-propane-thiols |
| 09/14/2011 | EP2073816B1 Boronic acids and esters as inhibitors of fatty acid amide hydrolase |